|
1.
|
Gleeson TG, Cheyne I, English JC, Quadri SM, Leipsic JA. A 50-year-old woman with a history of atrial fibrillation presents with acute dyspnea and pleuritic chest pain. Chest. 2010 May; 137(5):1225-30.
|
|
|
|
|
2.
|
Shafi S, Gatrad AR, Quadri SM, Sheikh A. Vaccinations for Hajj. J R Soc Promot Health. 2006 Mar; 126(2):68-9.
|
|
|
|
|
3.
|
de Perrot M, Quadri SM, Imai Y, Keshavjee S. Independent ventilation of the graft and native lungs in vivo after rat lung transplantation. Ann Thorac Surg. 2005 Jun; 79(6):2169-71.
|
|
|
|
|
4.
|
Quadri SM, Segall L, de Perrot M, Han B, Edwards V, Jones N, Waddell TK, Liu M, Keshavjee S. Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant. 2005 Feb; 5(2):292-9.
|
|
|
|
|
5.
|
Martins S, de Perrot M, Imai Y, Yamane M, Quadri SM, Segall L, Dutly A, Sakiyama S, Chaparro A, Davidson BL, Waddell TK, Liu M, Keshavjee S. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 2004 Dec; 11(24):1786-96.
|
|
|
|
|
6.
|
Mulay DV, Quadri SM. QT dispersion and early arrhythmic risk in acute myocardial infarction. Indian Heart J. 2004 Nov-Dec; 56(6):636-41.
|
|
|
|
|
7.
|
Borchardt PE, Vriesendorp HM, Freedman RS, Quadri SM. Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts. Cancer Biother Radiopharm. 2004 Feb; 19(1):43-51.
|
|
|
|
|
8.
|
Vriesendorp HM, Quadri SM. Radiolabeled immunoglobulin therapy: old barriers and new opportunities. Expert Rev Anticancer Ther. 2001 Oct; 1(3):461-78.
|
|
|
|
|
9.
|
Vriesendorp HM, Quadri SM. Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease. Cancer Biother Radiopharm. 2000 Oct; 15(5):431-45.
|
|
|
|
|
10.
|
Borchardt PE, Quadri SM, Freedman RS, Vriesendorp HM. Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis. Cancer Biother Radiopharm. 2000 Feb; 15(1):53-64.
|
|
|
|
|
11.
|
Lai J, Quadri SM, Borchardt PE, Harris L, Wucher R, Askew E, Schweichel L, Vriesendorp HM. Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3315s-3323s.
|
|
|
|
|
12.
|
Vriesendorp HM, Quadri SM, Wyllie CT, Lai J, Borchardt PE, Harris L, Wucher R, Askew E, Schweichler L. Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3324s-3329s.
|
|
|
|
|
13.
|
Quadri SM, Vriesendorp HM. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates. Q J Nucl Med. 1998 Dec; 42(4):250-61.
|
|
|
|
|
14.
|
Vriesendorp HM, Quadri SM, Borchardt PE. Tumour therapy with radiolabelled antibodies: optimisation of therapy. BioDrugs. 1998 Oct; 10(4):275-93.
|
|
|
|
|
15.
|
Borchardt PE, Quadri SM, Freedman RS, Vriesendorp HM. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice. J Nucl Med. 1998 Mar; 39(3):476-84.
|
|
|
|
|
16.
|
Vriesendorp FJ, Quadri SM, Flynn RE, Malone MR, Cromeens DM, Stephens LC, Vriesendorp HM. Preclinical analysis of radiolabeled anti-GD2 immunoglobulin G. Cancer. 1997 Dec 15; 80(12 Suppl):2642-9.
|
|
|
|
|
17.
|
Vriesendorp HM, Quadri SM, Andersson BS, Wyllie CT, Dicke KA. Recurrence of Hodgkin's disease after indium-111 and yttrium-90 labeled antiferritin administration. Cancer. 1997 Dec 15; 80(12 Suppl):2721-7.
|
|
|
|
|
18.
|
Borchardt PE, Quadri SM, Freedman RS, Vriesendorp HM. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts. Radiother Oncol. 1997 Sep; 44(3):283-93.
|
|
|
|
|
19.
|
Vriesendorp HM, Quadri SM, Jaeckle KA, Freedman RS, Cromeens DM. Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy. Radiother Oncol. 1996 Nov; 41(2):151-61.
|
|
|
|
|
20.
|
Quadri SM, Malik AB, Chu HB, Freedman RS, Vriesendorp HM. Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis. J Nucl Med. 1996 Sep; 37(9):1545-51.
|
|
|
|
|
21.
|
Ali MS, Quadri SM. Maleimido derivatives of diethylenetriaminepentaacetic acid and triethylenetetraaminehexaacetic acid: their synthesis and potential for specific conjugation with biomolecules. Bioconjug Chem. 1996 Sep-Oct; 7(5):576-83.
|
|
|
|
|
22.
|
Vriesendorp HM, Quadri SM, Andersson BS, Dicke KA. Hematologic side effects of radiolabeled immunoglobulin therapy. Exp Hematol. 1996 Aug; 24(10):1183-90.
|
|
|
|
|
23.
|
Delpassand ES, Yang DJ, Wallace S, Cherif A, Quadri SM, Price J, Joubert A, Inoue T, Podoloff DA. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue. J Pharm Sci. 1996 Jun; 85(6):553-9.
|
|
|
|
|
24.
|
Quadri SM, Malik AB, Tang XZ, Patenia R, Freedman RS, Vriesendorp HM. Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12. Cancer Res. 1995 Dec 1; 55(23 Suppl):5736s-5742s.
|
|
|
|
|
25.
|
Vriesendorp HM, Morton JD, Quadri SM. Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease. Cancer Res. 1995 Dec 1; 55(23 Suppl):5888s-5892s.
|
|
|
|
|
26.
|
Herpst JM, Klein JL, Leichner PK, Quadri SM, Vriesendorp HM. Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment. J Clin Oncol. 1995 Sep; 13(9):2394-400.
|
|
|
|
|
27.
|
Quadri SM, Siddiqui A, Klein JL, Vriesendorp HM. Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model. Nucl Med Biol. 1995 May; 22(4):413-23.
|
|
|
|
|
28.
|
Siddiqui A, Quadri SM, Griffiths GL, Goldenberg DM, Vriesendorp HM. Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14). Nucl Med Biol. 1995 May; 22(4):425-35.
|
|
|
|
|
29.
|
Wang S, Quadri SM, Tang XZ, Stephens LC, Lollo CP, Bartholomew RM, Vriesendorp HM. Liver toxicity induced by combined external-beam irradiation and radioimmunoglobulin therapy. Radiat Res. 1995 Mar; 141(3):294-302.
|
|
|
|
|
30.
|
Baranowska-Kortylewicz J, Dalrymple GV, Quadri SM, Harrison KA. Radiolabeling of antibodies for therapy and diagnosis. Methods Mol Biol. 1995; 51:423-39.
|
|
|
|
|
31.
|
Quadri SM, Lai J, Mohammadpour H, Vriesendorp HM, Williams JR. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model. J Nucl Med. 1993 Dec; 34(12):2152-9.
|
|
|
|
|
32.
|
Quadri SM, Shao Y, Blum JE, Leichner PK, Williams JR, Vriesendorp HM. Preclinical evaluation of intravenously administered 111In- and 90Y-labeled B72.3 immunoconjugate (GYK-DTPA) in beagle dogs. Nucl Med Biol. 1993 Jul; 20(5):559-70.
|
|
|
|
|
33.
|
Vriesendorp HM, Shao Y, Blum JE, Quadri SM, Williams JR. Fractionated intravenous administration of 90Y-labeled B72.3 GYK-DTPA immunoconjugate in beagle dogs. Nucl Med Biol. 1993 Jul; 20(5):571-8.
|
|
|
|
|
34.
|
Quadri SM, Vriesendorp HM, Leichner PK, Williams JR. Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs. J Nucl Med. 1993 Jun; 34(6):938-45.
|
|
|
|
|
35.
|
Bierman PJ, Vose JM, Leichner PK, Quadri SM, Armitage JO, Klein JL, Abrams RA, Dicke KA, Vriesendorp HM. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703.
|
|
|
|
|
36.
|
Vriesendorp HM, Quadri SM, Stinson RL, Onyekwere OC, Shao Y, Klein JL, Leichner PK, Williams JR. Selection of reagents for human radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1992; 22(1):37-45.
|
|
|
|
|
37.
|
Leichner PK, Vriesendorp HM, Hawkins WG, Quadri SM, Yang NC, Stinson RL, Loudenslager DM, Frankel TL, Chen XY, Klein JL. Quantitative SPECT for indium-111-labeled antibodies in the livers of beagle dogs. J Nucl Med. 1991 Jul; 32(7):1442-4.
|
|
|
|
|
38.
|
Paik CH, Yokoyama K, Reynolds JC, Quadri SM, Min CY, Shin SY, Maloney PJ, Larson SM, Reba RC. Reduction of background activities by introduction of a diester linkage between antibody and a chelate in radioimmunodetection of tumor. J Nucl Med. 1989 Oct; 30(10):1693-701.
|
|
|
|
